Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 SignalingDebra H. Josephs, Sophia N. Karagiannis, Heather J. Bax et al.|Cancer Research|2017Cited by 80
Abstract CT141: Phase 1 trial of MOv18, a first-in-class IgE antibody therapy for cancerJames Spicer, Sophia N. Karagiannis, Bristi Basu et al.|Cancer Research|2020Cited by 18
Supplementary Figure Legends from Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 SignalingDebra H. Josephs, Sophia N. Karagiannis, Heather J. Bax et al.|Unknown|2023Cited by 0
Supplementary Figure S4 from Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 SignalingDebra H. Josephs, Sophia N. Karagiannis, Heather J. Bax et al.|Unknown|2023Cited by 0
Supplementary Figure S4 from Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 SignalingDebra H. Josephs, Sophia N. Karagiannis, Heather J. Bax et al.|Unknown|2023Cited by 0